Skip to main content

Telehealth startup Cerebral to stop prescribing Adderall for new patients

By The Wall Street Journal  
   May 05, 2022

Company, which faces scrutiny over stimulant-prescription practices, will continue to prescribe other controlled substances.

Full story


Get the latest on healthcare leadership in your inbox.